Leaders in Changing the Process
Without Losing the Validated State
A validated process is a proven state: everything qualified, everything consistent with the filing, everything defensible. Then the supplier discontinues a component, the equipment ages out, the process gets an improvement, and the site expands. Every one of those is a controlled exit from the proven state and a controlled return to it. Change control is the machinery that makes that round trip safe — and it is one of the most-cited systems in regulatory inspections, because it is where good operations quietly drift away from their own filings.

Every change leaves the validated state on purpose. The system exists to bring you back with proof.
Strip away the forms and workflows and every change-control system is asking the same five things. A weak system asks them as checkboxes; a strong one demands answers with evidence attached.
Defined tightly enough that “like-for-like” means something. Vague scope is where drift begins.
The impact assessment: product quality, validation, stability, filings, other sites, other products. The honest blast radius.
Quality always; regulatory when filings are touched; the customer when agreements say so. Before, not after.
Requalification, verification runs, first-lot review — defined at approval, not improvised at closure.
Annual report, notification, or prior approval — the reporting category decided by assessment, not by convenience. For analytical methods, that decision is scoped years earlier under ICH Q14's established conditions.

Like-for-like or a new qualification? What must be revalidated? The assessment decides, not convenience.
Classification is where change control meets regulatory affairs. Call a moderate change minor and you have a data integrity problem; call it major and you have parked an improvement for a year. We calibrate the call, and file what follows.
| Change Magnitude | United States (FDA) | European Union (EMA) | Typical Examples |
|---|---|---|---|
| Minor | Annual Report | Type IA / IAIN variation | Tightened specs, editorial SOP updates, equivalent equipment swaps within the validated envelope. |
| Moderate | CBE-0 / CBE-30 | Type IB variation | New supplier of a non-critical excipient, site changes for testing, some analytical method changes. |
| Major | Prior Approval Supplement | Type II variation | Manufacturing site moves, process changes affecting sterility or bioavailability, new API source. |
Device side: the same discipline runs through 510(k) “letter-to-file vs. new submission” decisions and EU MDR significant-change assessments under MDCG 2020-3.

Everything downstream — the data, the filing, the launch date — hangs on getting this one call right.
Change control rarely fails loudly. It fails through small rationalizations that compound — until an investigator lines up the batch records against the filing and asks when, exactly, these became different documents.
A replacement part, a new lubricant, a software patch — waved through without assessment because it looked identical. The assessment is the only thing that makes that judgment true.
Every box ticked “no impact” by reflex, signed by people who saw the form for ninety seconds. The paperwork exists; the thinking never happened.
Your contract manufacturer improved something. Their change control worked; yours never heard about it. Your filing now describes a process that no longer exists.
Five individually-minor changes to the same process in two years, each fine alone, collectively a different process. Nobody was watching the cumulative drift.

A change is closed when the verification data says so, not when the implementation calendar does.
We design change control as a gated path with real decision points — light enough that engineers actually use it, rigorous enough that every gate leaves evidence an inspector can follow.
The change described precisely, with its reason and its urgency.
Cross-functional impact review: quality, validation, regulatory, supply.
Risk level and reporting category assigned, with rationale recorded.
The right signatures before work starts — quality holding the pen.
Implementation with the filing updated in step, not in arrears.
The pre-agreed evidence generated, reviewed, and judged.
Effectiveness confirmed, documents cut over, training done, drift check scheduled.

A label typo and a process change never fight for the same committee.
Change control judgment lives at the boundary of quality and regulatory. Your leads have run change boards at commercial scale, written the variations and supplements that followed, and cleaned up the drift when a system failed quietly for years.
One team that can both run the change board and write the PAS, variation, or letter-to-file it triggers.
Quality agreements and oversight cadences that make a partner’s changes visible before they become your surprise.
We triage and close change backlogs without the shortcuts that turn a backlog into a finding.
Gates proportionate to risk, so a label typo and a process change stop competing for the same committee.

A change system connects the quality floor to the regulatory filing. These are the services most often engaged with it.
The filings your changes must stay consistent with — and the supplements and variations they trigger.
Explore CMC →Established conditions and PACMPs: the modern toolkit for making post-approval change faster and safer.
Read the Analysis →The requalification work that brings changed equipment and systems back into the proven state.
Explore CQV →Tell us about the change on your desk, the backlog in your queue, or the system that needs rebuilding. We’ll match you with a senior change-control lead, with a response within one business day. All inquiries are strictly confidential.